Joseph L Goldstein

Dallas, TX, United States of America

Joseph L Goldstein

wikipediaNobel Prize
USPTO Granted Patents = 42 


Average Co-Inventor Count = 2.3

ph-index = 15

Forward Citations = 1,091(Granted Patents)


Location History:

  • Northridge, CA (US) (1978)
  • Westlake Village, CA (US) (1981 - 1984)
  • Pacific Palisades, CA (US) (1988 - 1998)
  • Los Angeles, CA (US) (2000 - 2012)
  • Dallas, TX (US) (1988 - 2015)

Company Filing History:


Years Active: 1978-2015

Loading Chart...
Loading Chart...
42 patents (USPTO):Explore Patents

Title: Inventor Joseph L. Goldstein: A Pioneer in RNA Technology

Introduction

Joseph L. Goldstein is a prominent inventor based in Dallas, TX, renowned for his groundbreaking contributions to the field of molecular biology and genetics. With an impressive portfolio of 42 patents, Goldstein is a key figure in the advancement of therapeutic applications related to RNA interference (RNAi) and gene modulation.

Latest Patents

One of Joseph L. Goldstein's latest patents focuses on the modulation of the SCAP gene through RNAi technology. The invention centers around a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of the Human SCAP gene. This dsRNA consists of an antisense strand that is less than 30 nucleotides in length, typically ranging from 19 to 25 nucleotides, and is substantially complementary to parts of the SCAP gene. Furthermore, the invention includes a pharmaceutical composition containing the dsRNA along with a pharmaceutically acceptable carrier. It proposes methods for treating diseases caused by the expression of the Human SCAP gene and outlines strategies for inhibiting this gene's expression in cellular environments.

Career Highlights

Joseph L. Goldstein's career has been marked by significant contributions to research and innovation. He has had a notable association with the University of Texas System, where he has engaged in cutting-edge research that has expanded the understanding of genetic modulation. His work has garnered attention for its implications in therapeutic contexts, particularly in treating diseases associated with aberrant gene expression.

Collaborations

Throughout his career, Goldstein has collaborated with esteemed colleagues, including Michael S. Brown and Yuval Reiss. These partnerships have enriched his research and propelled advancements in the field of molecular biology, highlighting the collaborative nature of scientific innovation.

Conclusion

Joseph L. Goldstein stands out as a leading inventor with a wealth of knowledge and experience in RNA technology. His latest inventions not only reflect his innovative spirit but also hold great promise for future therapeutic applications. As the world continues to grapple with genetic diseases, Goldstein's contributions may pave the way for new treatment modalities, solidifying his legacy in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…